The Danish company Orphazyme has acquired 10% of the shares in CombiGene

CombiGene AB (publ) (“CombiGene”, “the Company”) today announces that the Danish company Orphazyme gradually has acquired shares in CombiGene. Today, Orphazyme informed CombiGene that they in total have acquired approximately 10% of the outstanding shares in CombiGene, which makes Orphazyme one of the larger shareholders in the Company. CombiGene’s Board of Directors have begun a dialogue with Orphazyme.

For more information on Orphazyme, please visit: